Latest Clinical Trials
Moberg Derma starts recruiting patients for clinical phase III trial for its K301 product candidate to treat seborrheic dermatitis
A 2-week multiple ascending dose, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of oral AEB071, a protein kinase C inhibitor, in moderate to severe psoriasis patients
Early relief of atopic dermatitis symptoms with a novel hydrogel formulation of desonide 0.05% in pediatric subjects
The stratum corneum and atopic dermatitis: Moisturizing advantages of a novel desonide hydrogel treatment
The use of a responder analysis to identify clinical meaningful differences in patients suffering from chronic urticaria following a 4-weeks treatment with rupatadine 10- and 20 mg
Clinical response maintenance of etanercept intermittent therapy in psoriasis patients
Alopecia areata: Our experience with steroid treatment in AT/AU
Efficacy and safety of long-term etanercept therapy
Efalizumab treatment for moderate-severe psoriasis: Our experience in 27 patients
Juvenile pytiriasis rubra pilaris: Successful treatment with isotretinoin